RBC Bioscience

RBC Bioscience Debt Growth

The Year-over-Year Debt Growth of RBC Bioscience (6848.TWO) as of Oct 21, 2026 is 1.45 %. In the previous year, Year-over-Year Debt Growth was -2.10 % — a change of -168.97% (higher).

Debt Growth

1.45 %

YoY

-168.97%

Last updated:

Year-over-Year Debt Growth of RBC Bioscience is 2024 1.45 % . Year-over-Year Debt Growth of RBC Bioscience was 2023 -2.10 % . It decreases by -168.97% higher compared to the previous year.

The RBC Bioscience Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2019
97.57 TWD
Jan 1, 2020
27.03 TWD
Jan 1, 2021
324.15 TWD
Jan 1, 2022
-5.72 TWD
Jan 1, 2023
-2.10 TWD
Jan 1, 2024
1.45 TWD
The RBC Bioscience Debt Growth history
YEARDebt GrowthYoY
1.45 %-168.97%
-2.10 %-63.35%
-5.72 %-101.77%
324.15 %+1,099.03%
27.03 %-72.29%
97.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Year-over-Year Debt Growth of RBC Bioscience is 1.45 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — RBC Bioscience

All Key Metrics — RBC Bioscience